10/2008 - IMP321 IND Allowance in Pancreatic Cancer
Immutep S.A. announced today that the FDA, after review of the ...

---

06/2008 - LAG-3 Enhances Activity of a Cellular Cancer Immunotherapy
Immutep S.A. announced today the publication of research conducted by ...

---

11/2007 - IMP321 first results in metastatic breast cancer
Immutep S.A announced positive interim results from a Phase I/II ...

---

09/2007 - IMP321’s potency as a new immunopotentiator in cancer patients
Immutep Announces That ImmuFact® IMP321 Induces Activation of a Wide ...

---

09/2007 - Entering Phase I
lmmutep Announces That ImmuFact IMP321 Has Entered a Phase I ...